Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02168036 · ClinicalTrials.gov registry record
Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- 56
- Enrollment target
NCT02168036 is a clinical trial that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 56 participants.
The verdict
NCT02168036 was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The purpose of this protocol is to obtain biologic materials from the mediastinal lymph nodes from patients with lung disease and mediastinal lymph node involvement in order to: (1) develop a better understanding of the cause and development of lung disorders involving the mediastinal lymph nodes; (2) identify biologic parameters that help diagnose and predict the behavior of human lung diseases; and (3) identify individuals who will be suitable candidates for other protocols such as those involving investigational new drugs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-08-16 |
| Est. Completion | 2017-02-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02168036
The ClinicalTrials.gov registry entry for NCT02168036 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02168036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02168036 about?
NCT02168036 is a clinical study titled "Study of Biologic Materials From the Mediastinal Lymph Nodes From Patients With Lung Disease.". The purpose of this protocol is to obtain biologic materials from the mediastinal lymph nodes from patients with lung disease and mediastinal lymph node involvement in order to: (1) develop a better understanding of the cause and development of lung disorders involving the mediastinal lymph nodes; (...
What is the current status of trial NCT02168036?
This trial is currently terminated. The enrollment target is 56 participants. The study started on 2011-08-16. Estimated completion is 2017-02-16.
Who is sponsoring clinical trial NCT02168036?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.